openPR Logo
Press release

Lawsuit filed for Investors who lost money with shares of Orthofix Medical Inc. (NASDAQ: OFIX)

A lawsuit was filed on behalf of investors in Orthofix Medical Inc. (NASDAQ: OFIX) shares over alleged securities laws violations.

A lawsuit was filed on behalf of investors in Orthofix Medical Inc. (NASDAQ: OFIX) shares over alleged securities laws violations.

An investor, who purchased shares of Orthofix Medical Inc. (NASDAQ: OFIX), filed a lawsuit over alleged violations of Federal Securities Laws by Orthofix Medical Inc. in connection with certain allegedly false and misleading statements.

Investors who purchased shares of Orthofix Medical Inc. (NASDAQ: OFIX) have certain options and for certain investors are short and strict deadlines running. Deadline: October 21, 2024. NASDAQ: OFIX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Lewisville, TX based Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. On September 12, 2023, Orthofix Medical Inc. announced the termination of its CEO, CFO, and CLO. The Company stated, "The Board's decision follows an investigation conducted by independent outside legal counsel and directed and overseen by the Company's independent directors. As a result of the investigation, the Board determined that each of these executives engaged in repeated inappropriate and offensive conduct that violated multiple code of conduct requirements and was inconsistent with the Company's values and culture. These matters are unrelated to and do not impact the Company's strategy, results of operations or previously filed financial statements." Shares of Orthofix Medical Inc. (NASDAQ: OFIX) declined from $21.60 per share on August 31, 2023, to as low as $12.26 per share on September 22, 2023.

The plaintiff claims that between October 11, 2022, and September 12, 2023, the Defendants issued false and misleading statements and/or failed to disclose adverse facts about the Company's management team, that when the truth about the Company's management team was revealed, the price of Orthofix common stock suffered sharp declines and that as a result, investors who purchased shares of Orthofix Medical Inc. (NASDAQ: OFIX) suffered significant losses and damages.

Those who purchased shares of Orthofix Medical Inc. (NASDAQ: OFIX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors who lost money with shares of Orthofix Medical Inc. (NASDAQ: OFIX) here

News-ID: 3647217 • Views:

More Releases from Shareholders Foundation, Inc.

Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potential Wrongdoing
Novo Nordisk A/S (NYSE: NVO) Long Term Investor Alert: Investigation of potentia …
An investigation on behalf of current long-term investors in shares of Novo Nordisk A/S (NYSE: NVO) concerning potential breaches of fiduciary duties by certain directors and officers was announced. Investors who are current long term investors in Novo Nordisk A/S (NYSE: NVO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for long term investors in
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ: FTNT)
Lawsuit filed for Investors who lost money with shares of Fortinet, Inc. (NASDAQ …
An investor, who purchased shares of Fortinet, Inc. (NASDAQ: FTNT), filed a lawsuit over alleged violations of Federal Securities Laws by Fortinet, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Fortinet, Inc. (NASDAQ: FTNT) have certain options and for certain investors are short and strict deadlines running. Deadline: November 21, 2025. NASDAQ: FTNT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on October 07, 2025
CTO Realty Growth, Inc. (NYSE: CTO) Investor Alert: Deadline in Lawsuit on Octob …
A deadline is coming up on October 07, 2025in the lawsuit filed for certain investors of CTO Realty Growth, Inc. (NYSE: CTO) over alleged securities laws violations by CTO Realty Growth, Inc. Investors who purchased shares of CTO Realty Growth, Inc. (NYSE: CTO) have certain options and there are strict and short deadlines running. Deadline: October 07, 2025. CTO Realty Growth, Inc. (NYSE: CTO) stockholders should contact the Shareholders Foundation at
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR)
Alert: Lawsuit filed for Investors who lost money with shares of Jasper Therapeu …
An investor, who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR), filed a lawsuit over alleged violations of Federal Securities Laws by Jasper Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Jasper Therapeutics, Inc. (NASDAQ: JSPR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 18, 2025. NASDAQ: JSPR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for Orthofix

Orthobiologics Market Growth Statistics & Future Prospects | Medtronic, Orthofix …
The latest study released on the Global Orthobiologics Market by HTF MI Research evaluates market size, trend, and forecast to 2031. The Orthobiologics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in This
Extremity Reconstruction Market Hits New High | Major Giants Orthofix,TriMed,Bio …
HTF MI just released the Global Extremity Reconstruction Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Major companies profiled in Extremity Reconstruction Market are: Stryker, Zimmer Biomet,
Osgood-Schlatter Market is Experiencing Significant Growth | Bioventus, Acumed, …
The Latest published market study on Global Osgood-Schlatter Market provides an overview of the current market dynamics in the Osgood-Schlatter, as well as what our survey respondents all outsourcing decision-makers predict the market will look like in 2032. The study breaks the market by revenue and volume (wherever applicable) and price history to estimate the size and trend analysis and identify gaps and opportunities. Some of the players that are
Spinal Implants Market Dynamics 2028 | Orthofix International N.V.
Global Spinal Implants Market: Overview Rapidly growing population and significantly increase in the treatment rate of degenerative spine disorders are the key factors driving demand in the global spinal implants market. Changing the lifestyle that led to the growth of obesity among the masses has further augmented growth for spinal implants. Increasing spine injuries due to increasing sports activities and other reasons are also benefitting growth in this market. Moreover, the
Radiolucent Wrist Fixator Market 2018 - 2028 | Orthofix, Stryker, Smith & Nephew
Market Outlook External fixation devices have been used since a long time. However, these external fixation devices have a number of drawbacks such as risk of infection, stiffness of the joint, discomfort due to weight and hindrance in X-Ray for monitoring the heeling progress. The radiolucent wrist fixators help in reducing the bulk as they are lighter making them a convenient option for patients. External fixation devices can be used for
Medical Bionic Implant Market to 2019 – 2024: Opportunity & Growth Analysis by …
A fresh report has been added to the wide database of Business Industry Reports. The research study is titled “Medical Bionic Implant Market” by Manufacturers, Countries, Type and Application, Forecast to 2024 which provides important data about the production, consumption, revenue and company profiles for key industry participants. Global Medical Bionic Implant Market Synopsis: This report studies the Global Medical Bionic Implant Market over the forecast period of 2019 to 2024. The